OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao, Dongjuan Yang, Yan Fang, et al.
Theranostics (2018) Vol. 9, Iss. 1, pp. 126-151
Open Access | Times Cited: 166
Shan Gao, Dongjuan Yang, Yan Fang, et al.
Theranostics (2018) Vol. 9, Iss. 1, pp. 126-151
Open Access | Times Cited: 166
Showing 1-25 of 166 citing articles:
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Shreya Thakkar, Dilip Kumar Sharma, Kiran Kalia, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 43-68
Closed Access | Times Cited: 273
Shreya Thakkar, Dilip Kumar Sharma, Kiran Kalia, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 43-68
Closed Access | Times Cited: 273
Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
Weijing Yang, Fuwu Zhang, Hongzhang Deng, et al.
ACS Nano (2019) Vol. 14, Iss. 1, pp. 620-631
Closed Access | Times Cited: 231
Weijing Yang, Fuwu Zhang, Hongzhang Deng, et al.
ACS Nano (2019) Vol. 14, Iss. 1, pp. 620-631
Closed Access | Times Cited: 231
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Qianqian Ni, Fuwu Zhang, Yijing Liu, et al.
Science Advances (2020) Vol. 6, Iss. 12
Open Access | Times Cited: 215
Qianqian Ni, Fuwu Zhang, Yijing Liu, et al.
Science Advances (2020) Vol. 6, Iss. 12
Open Access | Times Cited: 215
Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view
Xingyue Huang, Yang Lu, Mingxue Guo, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7546-7569
Open Access | Times Cited: 176
Xingyue Huang, Yang Lu, Mingxue Guo, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7546-7569
Open Access | Times Cited: 176
Sequential PDT and PTT Using Dual‐Modal Single‐Walled Carbon Nanohorns Synergistically Promote Systemic Immune Responses against Tumor Metastasis and Relapse
Jingxing Yang, Mengfei Hou, Wenshe Sun, et al.
Advanced Science (2020) Vol. 7, Iss. 16
Open Access | Times Cited: 166
Jingxing Yang, Mengfei Hou, Wenshe Sun, et al.
Advanced Science (2020) Vol. 7, Iss. 16
Open Access | Times Cited: 166
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
Pengcheng Zhang, Yihui Zhai, Ying Cai, et al.
Advanced Materials (2019) Vol. 31, Iss. 49
Closed Access | Times Cited: 149
Pengcheng Zhang, Yihui Zhai, Ying Cai, et al.
Advanced Materials (2019) Vol. 31, Iss. 49
Closed Access | Times Cited: 149
Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
Shuang Liang, Jianjun Yao, Dan Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 126
Shuang Liang, Jianjun Yao, Dan Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 126
Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
Shuangneng Yin, Zhaojun Chen, Dugang Chen, et al.
Theranostics (2023) Vol. 13, Iss. 5, pp. 1520-1544
Open Access | Times Cited: 62
Shuangneng Yin, Zhaojun Chen, Dugang Chen, et al.
Theranostics (2023) Vol. 13, Iss. 5, pp. 1520-1544
Open Access | Times Cited: 62
Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy
Beibei Chen, Kangli Guo, Xiaoyi Zhao, et al.
Exploration (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 51
Beibei Chen, Kangli Guo, Xiaoyi Zhao, et al.
Exploration (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 51
Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 290-348
Closed Access | Times Cited: 47
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 290-348
Closed Access | Times Cited: 47
Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
Soroush Karimi, Roksana Bakhshali, Soheil Bolandi, et al.
Materials Today Bio (2025) Vol. 31, pp. 101626-101626
Open Access | Times Cited: 2
Soroush Karimi, Roksana Bakhshali, Soheil Bolandi, et al.
Materials Today Bio (2025) Vol. 31, pp. 101626-101626
Open Access | Times Cited: 2
Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells
Ling Li, Jianhua Zou, Yunlu Dai, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 11, pp. 1102-1116
Closed Access | Times Cited: 133
Ling Li, Jianhua Zou, Yunlu Dai, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 11, pp. 1102-1116
Closed Access | Times Cited: 133
Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
Seungho Lim, Jooho Park, Man Kyu Shim, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7906-7923
Open Access | Times Cited: 129
Seungho Lim, Jooho Park, Man Kyu Shim, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7906-7923
Open Access | Times Cited: 129
Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy
Xiangyu Meng, Xuezhong Zhang, Mei Liu, et al.
Applied Materials Today (2020) Vol. 21, pp. 100864-100864
Closed Access | Times Cited: 122
Xiangyu Meng, Xuezhong Zhang, Mei Liu, et al.
Applied Materials Today (2020) Vol. 21, pp. 100864-100864
Closed Access | Times Cited: 122
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
Huijuan Song, Pengxiang Yang, Pingsheng Huang, et al.
Theranostics (2019) Vol. 9, Iss. 8, pp. 2299-2314
Open Access | Times Cited: 112
Huijuan Song, Pengxiang Yang, Pingsheng Huang, et al.
Theranostics (2019) Vol. 9, Iss. 8, pp. 2299-2314
Open Access | Times Cited: 112
Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment
Zijian Zhou, Kaiyuan Ni, Hongzhang Deng, et al.
Advanced Drug Delivery Reviews (2020) Vol. 158, pp. 73-90
Closed Access | Times Cited: 109
Zijian Zhou, Kaiyuan Ni, Hongzhang Deng, et al.
Advanced Drug Delivery Reviews (2020) Vol. 158, pp. 73-90
Closed Access | Times Cited: 109
Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery
Xiaobin Chen, Maoli Wang, Xiaowei Yang, et al.
Theranostics (2019) Vol. 9, Iss. 21, pp. 6080-6098
Open Access | Times Cited: 105
Xiaobin Chen, Maoli Wang, Xiaowei Yang, et al.
Theranostics (2019) Vol. 9, Iss. 21, pp. 6080-6098
Open Access | Times Cited: 105
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
E. Pavitra, Begum Dariya, Gowru Srivani, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 293-306
Closed Access | Times Cited: 104
E. Pavitra, Begum Dariya, Gowru Srivani, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 293-306
Closed Access | Times Cited: 104
Peptide-based materials for cancer immunotherapy
Lu Zhang, Yanyu Huang, Aaron Lindstrom, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7807-7825
Open Access | Times Cited: 102
Lu Zhang, Yanyu Huang, Aaron Lindstrom, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7807-7825
Open Access | Times Cited: 102
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Yun Liu, Jianfeng Guo, Leaf Huang
Theranostics (2020) Vol. 10, Iss. 7, pp. 3099-3117
Open Access | Times Cited: 102
Yun Liu, Jianfeng Guo, Leaf Huang
Theranostics (2020) Vol. 10, Iss. 7, pp. 3099-3117
Open Access | Times Cited: 102
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
Lin Qin, Huilin Zhang, Yang Zhou, et al.
Small (2021) Vol. 17, Iss. 28
Closed Access | Times Cited: 87
Lin Qin, Huilin Zhang, Yang Zhou, et al.
Small (2021) Vol. 17, Iss. 28
Closed Access | Times Cited: 87
Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression
Linlin Shi, Jianyong Sheng, Mengli Wang, et al.
Theranostics (2019) Vol. 9, Iss. 14, pp. 4115-4129
Open Access | Times Cited: 86
Linlin Shi, Jianyong Sheng, Mengli Wang, et al.
Theranostics (2019) Vol. 9, Iss. 14, pp. 4115-4129
Open Access | Times Cited: 86
Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer
Xianli Hu, Bo Hou, Zhiai Xu, et al.
Advanced Science (2020) Vol. 7, Iss. 8
Open Access | Times Cited: 84
Xianli Hu, Bo Hou, Zhiai Xu, et al.
Advanced Science (2020) Vol. 7, Iss. 8
Open Access | Times Cited: 84
